MiR-26b modulates insulin sensitivity in adipocytes by interrupting the PTEN/PI3K/AKT pathway. (Q53842061)

20 May 2018

title

MiR-26b modulates insulin sensitivity in adipocytes by interrupting the PTEN/PI3K/AKT pathway. (English)

1 reference

20 May 2018

1 reference

1 reference

G Xu

1

1 reference

20 May 2018

C Ji

2

1 reference

20 May 2018

G Song

3

1 reference

20 May 2018

C Zhao

4

1 reference

20 May 2018

C Shi

5

1 reference

20 May 2018

L Song

6

1 reference

20 May 2018

L Chen

7

1 reference

20 May 2018

L Yang

8

1 reference

20 May 2018

F Huang

9

1 reference

20 May 2018

L Pang

10

1 reference

20 May 2018

N Zhang

11

1 reference

20 May 2018

Y Zhao

12

1 reference

20 May 2018

X Guo

13

1 reference

20 May 2018

language of work or name

English

0 references

publication date

22 May 2015

1 reference

20 May 2018

International Journal of Obesity

published in

1 reference

20 May 2018

volume

39

1 reference

20 May 2018

page(s)

1523-1530

1 reference

20 May 2018

issue

10

1 reference

20 May 2018

https://scigraph.springernature.com/pub.10.1038/ijo.2015.95

exact match

0 references

cites work

Global burden of obesity in 2005 and projections to 2030.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Childhood obesity in developing countries: epidemiology, determinants, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Cohort profile: the Fangshan Cohort Study of cardiovascular epidemiology in Beijing, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Obesity prevalence in Colombian adults is increasing fastest in lower socio-economic status groups and urban residents: results from two nationally representative surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

MicroRNAs in metabolism and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

MicroRNAs in adipose tissue: their role in adipogenesis and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

A pancreatic islet-specific microRNA regulates insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Role of microRNAs in obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

MicroRNAs in adipogenesis and as therapeutic targets for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Role of microRNA-21 in regulating 3T3-L1 adipocyte differentiation and adiponectin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

MicroRNA-143 regulates adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

MicroRNA-146b promotes adipogenesis by suppressing the SIRT1-FOXO1 cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

MicroRNA-344 inhibits 3T3-L1 cell differentiation via targeting GSK3β of Wnt/β-catenin signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

A novel negative regulator of adipogenesis: microRNA-363.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

The role of microRNA-26b in human adipocyte differentiation and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Modulation of hsa-miR-26b levels following adipokine stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

MicroRNAs 103 and 107 regulate insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Point: visceral adiposity is causally related to insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Role of microRNA-26b in glioma development and its mediated regulation on EphA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Identification of differentially expressed microRNA in parathyroid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Critical nodes in signalling pathways: insights into insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Selective deletion of Pten in pancreatic beta cells leads to increased islet mass and resistance to STZ-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Muscle-specific Pten deletion protects against insulin resistance and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

PTEN mutations as a cause of constitutive insulin sensitivity and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Association of the polymorphisms in the 5′‐untranslated region of PTEN gene with type 2 diabetes in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Treatment of HCV infection by targeting microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

Expression of microRNA-26b, an obesity-related microRNA, is regulated by free fatty acids, glucose, dexamethasone and growth hormone in human adipocytes

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25999046

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.95

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/IJO.2015.95

1 reference

20 May 2018

PubMed ID

25999046

1 reference

20 May 2018